SPRUCE POWER HOLDING CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SPRUCE POWER HOLDING CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $23.19M | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $20.34M | Mar 1, 2022 |
| FY2021 | Dec 31, 2019 | $7.22M | Mar 1, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $111.81M | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | $82.11M | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | $79.86M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $23.19M | Apr 9, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | ($696.0K) | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $2.74M | Mar 1, 2022 |
| FY2021 | Dec 31, 2019 | ($860.0K) | Mar 1, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($26.03M) | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | ($70.49M) | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | ($65.83M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($93.93M) | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | $28.79M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($60.61M) | Mar 1, 2022 |
| FY2019 | Dec 31, 2019 | $1.21M | Mar 30, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.94M | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | ($50.39M) | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | ($36.82M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($59.29M) | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | ($35.09M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($15.29M) | Mar 1, 2022 |
| FY2019 | Dec 31, 2019 | ($393.3K) | Mar 30, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $10.78M | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $4.45M | Mar 1, 2022 |
| FY2021 | Dec 31, 2019 | $2.87M | Mar 1, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.11M | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | $58.89M | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | $56.12M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $73.12M | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | $35.09M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $13.59M | Mar 1, 2022 |
| FY2021 | Dec 31, 2019 | $9.84M | Mar 1, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.53M) | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | ($41.81M) | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | ($33.66M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($63.49M) | Apr 9, 2024 |
| FY2021 | Dec 31, 2021 | ($48.49M) | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | ($19.88M) | Mar 1, 2022 |
| FY2019 | Dec 31, 2019 | ($624.4K) | Mar 30, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $221.0K | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | $354.0K | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | $499.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Apr 9, 2024 |
| FY2021 | Dec 31, 2021 | $3.64M | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $145.0K | Mar 1, 2022 |
| FY2021 | Dec 31, 2019 | $28.0K | Mar 1, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $837.27M | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | $898.48M | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | $895.02M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $826.55M | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | $393.22M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $347.01M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $9.25M | May 17, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $716.02M | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | $752.33M | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | $680.35M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $537.58M | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | $31.41M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $158.12M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $22.95M | May 17, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $361.81M | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $188.90M | Mar 1, 2022 |
| FY2021 | Dec 31, 2019 | ($13.70M) | Mar 1, 2022 |
| FY2021 | Dec 31, 2018 | $846.0K | Mar 1, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | Mar 31, 2025 |
| FY2025 | Dec 31, 2023 | $28.80M | Apr 3, 2026 |
| FY2023 | Dec 31, 2022 | $128.55M | Apr 9, 2024 |
| FY2022 | Sep 9, 2022 | $158.64M | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $489.0K | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $489.0K | May 17, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($354.40M) | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | ($328.38M) | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | ($257.89M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($193.34M) | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | ($99.41M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($128.20M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | ($67.60M) | May 17, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.84M | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | $72.80M | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | $141.35M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $220.32M | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | $351.68M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $329.64M | Mar 1, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $695.52M | Apr 3, 2026 |
| FY2024 | Dec 31, 2024 | $730.62M | Mar 31, 2025 |
| FY2023 | Dec 31, 2023 | $646.72M | Apr 9, 2024 |
| FY2022 | Dec 31, 2022 | $533.17M | Mar 30, 2023 |
| FY2021 | Dec 31, 2021 | $21.0K | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $98.0K | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.85M | May 17, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | (3) | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | (3) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (5) | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 1, 2022 |
| FY2021 | Dec 31, 2019 | 0 | Mar 1, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | (3) | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | (3) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (5) | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 1, 2022 |
| FY2021 | Dec 31, 2019 | 0 | Mar 1, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.17M | Apr 3, 2026 |
| FY2025 | Dec 31, 2024 | 18.31M | Apr 3, 2026 |
| FY2024 | Dec 31, 2023 | 18.29M | Mar 31, 2025 |
| FY2024 | Oct 6, 2023 | 18.20M | Mar 31, 2025 |
| FY2024 | Oct 5, 2023 | 145.60M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 18.05M | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | 140.54M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 131.37M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 80.40M | May 17, 2021 |